Beatrice Malacrida

3PUBLICATIONS
42CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Apr 28, 2025
Navitoclax, a Bcl-2/xL Inhibitor, and YM155, a Survivin Inhibitor, in Combination with Carboplatin, Effectively Inhibit Ovarian Cancer Tumor Growth.

Hilary A Kenny, Carman Ka Man Ip, Lucy Kelliher

|May 31, 2024
Human 3D Ovarian Cancer Models Reveal Malignant Cell-Intrinsic and -Extrinsic Factors That Influence CAR T-cell Activity.

Joash D Joy, Beatrice Malacrida, Florian Laforêts

|Jun 30, 2022
A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1β.

Irene Olivera, Rebeca Sanz-Pamplona, Elixabet Bolaños

Pageof 1

Frequent Collaborators

3 joint publications

Frances R Balkwill

1 joint publications

Irene Olivera

1 joint publications

Rebeca Sanz-Pamplona

1 joint publications

Elixabet Bolaños

1 joint publications

Inmaculada Rodriguez

1 joint publications

Iñaki Etxeberria

1 joint publications

Assunta Cirella

1 joint publications

Josune Egea

1 joint publications

Saray Garasa

1 joint publications

Itziar Migueliz

Frequent Collaborators

3 joint publications

Frances R Balkwill

1 joint publications

Irene Olivera

1 joint publications

Rebeca Sanz-Pamplona

1 joint publications

Elixabet Bolaños

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

27.0K
Heterotypic Three-dimensional <em>In Vitro</em> Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
12:42

Heterotypic Three-dimensional <em>In Vitro</em> Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on : Aug 28, 2012

15.1K
Generation of Orthotopic Pancreatic Tumors and <i>Ex vivo</i> Characterization of Tumor-Infiltrating T Cell Cytotoxicity
06:16

Generation of Orthotopic Pancreatic Tumors and <i>Ex vivo</i> Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on : Dec 07, 2019

12.9K
See more related videos

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

27.0K
Heterotypic Three-dimensional <em>In Vitro</em> Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
12:42

Heterotypic Three-dimensional <em>In Vitro</em> Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression

Published on : Aug 28, 2012

15.1K
Generation of Orthotopic Pancreatic Tumors and <i>Ex vivo</i> Characterization of Tumor-Infiltrating T Cell Cytotoxicity
06:16

Generation of Orthotopic Pancreatic Tumors and <i>Ex vivo</i> Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on : Dec 07, 2019

12.9K
See more related videos